Bio-Path Holdings Reports Fiscal Year 2013 Operational and Financial Results PR_2013_Earnings_Release
Bio-Path Holdings, Inc. to Raise $10 Million in Registered Direct Offering BPTH_to_Raise_10_mil_2014_01_16
Bio-Path Holdings to Present at the Biotech Showcase 2014 Conference in San Francisco, CA on Wednesday, January 15, 2014 at 8:00 a.m. Pacific Time PR_Biotech_Showcase_2014
Preliminary Results from Bio-Path Holdings’ Phase I Clinical Trial Presented at the Annual Meeting of the American Society of Hematology (ASH) in New Orleans ASH_Meeting_Poster_Presentation_Dec2013
Bio-Path Holdings Reports Third Quarter 2013 Operational and Financial Results PR_Third_Quarter_2013_Earnings
Data from Bio-Path Holdings Phase I Clinical Trial in Hematological Cancers to be Presented at American Society of Hematology Annual Meeting: Data Suggests Potential for AML and MDS Disease Inhibition with Liposomal Grb-2- BPTH_PR_Presentation_at_ASH_Annual_Meeting
Bio-Path Holdings to Present at the 12th Annual BIO Investor Forum PR_Bio_Path_To_Present_at_Bio_Investor_Forum
